The Paris Private Equity team advised Cerba HealthCare on its acquisition of Groupe Bio7, a French network of medical testing laboratories, from Ardian, a world-leading private investment house, its founder and its management.
Cerba HealthCare, the European leader in clinical pathology and medical biology is involved in three complementary segments: local clinical pathology, specialized clinical pathology and central lab testing for clinical trials. With this operation, Cerba HealthCare aims to strengthen its services of proximity biology.
The Goodwin team was led by partners Maxence Bloch and William Robert and included partners Marie-Laure Bruneel and Frédéric Guilloux; and associates Chloe Vu-Thien, Samuel Berrebbi and Laurent Bonnet.
For additional details on the acquisition, please read the press release.